🇺🇸 nitroglycerine in United States

1,280 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myocardial Infarction — 150 reports (11.72%)
  2. Dyspnoea — 149 reports (11.64%)
  3. Chest Pain — 145 reports (11.33%)
  4. Chronic Kidney Disease — 140 reports (10.94%)
  5. Nausea — 131 reports (10.23%)
  6. Fatigue — 125 reports (9.77%)
  7. Renal Failure — 114 reports (8.91%)
  8. Dizziness — 113 reports (8.83%)
  9. Acute Kidney Injury — 112 reports (8.75%)
  10. Asthenia — 101 reports (7.89%)

Source database →

Other Metabolic approved in United States

Frequently asked questions

Is nitroglycerine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for nitroglycerine in United States?

University Hospital, Ghent is the originator. The local marketing authorisation holder may differ — check the official source linked above.